The global neonatal and intensive care landscape of early 2026 is increasingly defined by the integration of precision gas therapy to manage complex respiratory failure. Inhaled Nitric Oxide (iNO) delivery systems—highly specialized medical devices designed to deliver controlled concentrations of nitric oxide gas—have emerged as a life-saving intervention for persistent pulmonary...